Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.26% is 38% below its 5-year average of 0.42%, near the low end of its 5-year range (0.00%–1.90%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.80% below its 12-month average of 0.28%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.26%.
DEBT TO ASSETS RATIO
0.26%
DEBT TO ASSETS RATIO AVG TTM
0.28%
DEBT TO ASSETS RATIO AVG 3Y
0.68%
DEBT TO ASSETS RATIO AVG 5Y
0.42%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-4.80%
CURRENT VS 3Y AVG
-61.46%
CURRENT VS 5Y AVG
-37.75%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+191.02%
vs the sector median at left
PRF Technologies Ltd.
Market Cap
$70868.00
Debt to Assets Ratio
0.26%
TTM Avg
0.28%
3Y Avg
0.68%
5Y Avg
0.42%
Market Cap
$96046.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$109148.00
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$28787.00
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6102.00
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$358320.00
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PRF Technologies Ltd. (PRFX) | $70868.00 | 0.26% | 0.28% | 0.68% | 0.42% |
| Akanda Corp. (AKAN)vs › | $61172.00 | 2.89% | N/A | N/A | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $96046.00 | 0.00% | N/A | N/A | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109148.00 | 0.33% | N/A | N/A | N/A |
| Zhongchao Inc. (ZCMD)vs › | $30562.00 | 0.00% | N/A | N/A | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $28787.00 | 0.01% | N/A | N/A | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6102.00 | 0.15% | N/A | N/A | N/A |
| SciSparc Ltd. (SPRC)vs › | $246973.00 | 0.05% | N/A | N/A | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $358320.00 | 0.05% | N/A | N/A | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $401484.00 | 0.18% | N/A | N/A | N/A |
Debt/Assets
0.3%
Debt/Equity
0.00
Current Ratio
5.07
Interest Coverage
-498.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.26% |
| 2026-03-31 | 0.26% |
| 2025-12-31 | 0.18% |
| 2025-09-30 | 0.18% |
| 2025-06-30 | 0.50% |
| 2025-03-31 | 0.50% |
| 2024-12-31 | 0.99% |
| 2024-09-30 | 0.99% |
| 2024-06-30 | 1.90% |
| 2024-03-31 | 1.34% |
| 2023-12-31 | 0.87% |
| 2023-09-30 | 0.86% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-06-30 | 810.74% |
| 2019-12-31 | 530.33% |
| 2019-09-30 | 530.33% |
| 2019-06-30 | 4300.00% |
| 2019-03-31 | 4300.00% |
| 2018-12-31 | 5580.25% |
| 2018-09-30 | 5580.25% |
